A veto worth having

Patients will accept medical AI on one condition: that a doctor can overrule it. That veto is being sold and stretched faster than anyone is paying to keep it real.

Illustration: a control box with a red button on a table, connected by cables to nine small screens mounted on a wall.

Asked whether they would let software decide their diagnosis and treatment with no doctor reviewing it, fewer than one American patient in ten said yes. Add a single condition, that their own doctor could change or override the machine's decision, and the share rose to more than half. The survey, by West Health and Gallup and published on November 9, also asked primary care physicians to guess how their patients would answer. They guessed little more than a third.

Patients, in other words, fear the machine less than they fear the machine alone. The doctor's power to overrule is what makes medical AI acceptable to the public, and this week it was claimed, sold and stretched all at once. That veto is being spread thinner faster than anyone is paying to keep it real, and it should be protected in law, staffed in contracts and counted before it becomes a formality.

Doctors' organizations moved first to claim it. On November 9 the American Medical Association's House of Delegates, meeting in Orlando, voted that AI cannot hold a medical license, a physician's title or certification to practice, and that it belongs in teams led by physicians. The policy would put the cost of a defective product's errors on its vendor when a doctor has used it as intended, and on the hospital or insurer as well when they mandate a particular tool. It also seeks legal protection for physicians who decline to use an AI tool or to follow its advice. Dr. Willie Underwood III, the AMA's president, said that "patients deserve to know who is responsible for their care."

The veto is already exercised every day, with little preparation. In a Doximity survey of physicians in September, just over half said they used AI at work daily, and three in four had come across a factual error in its answers in the past year. Fewer than three in ten said their organization had clear policies and approvals for its use, and Gallup found that most primary care doctors had received no formal training in it at all. Doximity sells AI tools of its own, which makes its tally of errors the more striking.

Meanwhile the veto is being priced. On November 10 Oura, which makes a smart ring, agreed to pay $625 million in cash for Counsel Health, which lets patients move within minutes from its AI chat to a board-certified physician who can diagnose and prescribe. Counsel's chief executive describes its safety approach as "keeping physicians in the loop for clinical decisions." The announcement cited satisfaction scores, no clinical outcomes and no figure for how many patients each of its doctors looks after.

Inside hospitals the same arithmetic is at work. HCA Healthcare expects about 10,000 of its physicians to be using an ambient scribe, software that listens to a visit and drafts the note, by the end of the year, and its chief clinical officer, Dr. Michael Schlosser, told Becker's that it saves one to two hours a shift. Becker's reported that outpatient clinics have seen more throughput as physicians chose to add patients to their schedules. Google opened a preview of an agent that reads records in Epic and billing systems and prepares prior authorizations, the paperwork insurers demand before they will pay for a treatment; it can read records but not change them, leaving decisions to a doctor or nurse. Northwell Health's chief executive, John D'Angelo, told Fortune that he has about 400 employees whose sole job is fighting insurance denials. An analysis of Medicare billing in NEJM AI found that family and internal medicine have among the least physical protection from substitution by AI, so the hours a machine frees in those fields are the easiest to refill.

The week's evidence suggests the human check still earns its keep. Across more than two million encounters at 15 Danish hospitals, a machine-learning warning score added almost nothing to the National Early Warning Score, a simple tally of vital signs, except in the sickest patients. Dr. Roy Perlis of Massachusetts General Hospital showed that a hidden adjustment to a chatbot's internal workings could steer its depression advice away from antidepressants, a change he wrote would be invisible to a patient or a clinician. A veto cannot catch what it cannot see, which is why the AMA also wants vendors to disclose their products' limitations and performance data.

Technologists will reply that a veto exercised on every decision defeats the purpose. If software is right more often than a tired doctor, a mandatory human check preserves the bottleneck and the cost that AI was meant to remove, and patients' comfort with autonomy will grow as the tools prove themselves. That may well happen. But comfort should follow evidence, and the week supplied little of it: Counsel's announcement reported no outcomes, the Danish model barely improved on a simple vital-sign score outside the sickest patients, and a randomized trial of a maternal-health chatbot found no effect on anxiety or depression at a year. Until products show results in ordinary practice, the doctor's override is the main safeguard patients have, and an override squeezed between extra appointments protects nobody.

Legislators should enact what the AMA asked for: no liability for a physician who reasonably declines an AI recommendation, and no contract that shifts a defective product's failures onto the doctor who used it. Insurers should adopt the rule Alabama has written into law, that a licensed physician or other health professional makes every prior-authorization denial on grounds of medical necessity. Hospitals and medical staffs should write the clear AI policies that most physicians in the Doximity survey did not report having, train clinicians before a tool is switched on, and decide in writing, before an ambient scribe goes live, how much of the time it saves goes back into the schedule. Companies that sell care backed by a physician should publish how many patients each doctor oversees and how often doctors overrule the machine, and physicians should ask their employers for the same two numbers this month.

Patients have named their price for accepting the machine: a doctor who can say no. Medicine should make sure that doctor has the time, the training and the legal cover to say it.

  • The American Medical Association's House of Delegates adopted policy Nov. 9 at its Interim Meeting in Orlando stating that AI cannot be granted physician licensure, professional titles or certification to practice medicine and should be used in physician-led teams. When a physician uses a clinical AI product as intended and exercises appropriate judgment, liability for a defective product's errors would fall on the vendor, manufacturer or distributor, and when a hospital, health system, insurer or other entity mandates a tool, on that entity and the vendor. The AMA will also seek laws protecting physicians from liability for choosing not to use an AI tool or not to follow its recommendation, and requiring vendors to carry liability insurance and disclose product limitations and performance data.
  • In a West Health-Gallup survey of 5,330 adults who had seen a primary care provider in the past year, conducted Aug. 12 to 24, 56% said they would be comfortable with AI making diagnosis and treatment decisions as long as their provider could change or override them, and 9% with no provider review. In a companion survey of 1,007 primary care physicians, conducted Aug. 7 to 23, physicians estimated those shares at 36% and 6%. Eighty-nine percent of the physicians had used AI for at least one work task in the past year, and 20% had received any formal training in using AI in health care.
  • Doximity, which sells AI tools for clinicians, surveyed 3,379 U.S. physician members in 20 specialties in September 2026. Fifty-two percent said they use AI daily, up from 37% in 2025, and 85% at least weekly; three in four had encountered a factual inaccuracy in the past 12 months, and two-thirds said they verify AI-generated clinical information all or almost all of the time. Only 28% said clear policies and approvals were in place at their organization, and about three in four said patients had become more likely in the past six months to propose a self-diagnosis or treatment plan from a generative AI tool.
  • Oura signed a definitive agreement announced Nov. 10 to acquire Counsel Health for $625 million in cash, subject to purchase price adjustments, with closing expected before the end of the calendar year. Counsel's AI draws on medical records, guidelines and biometric data, and members can escalate to a board-certified Counsel physician within minutes who can provide diagnoses, prescriptions and referrals. The release reports satisfaction measures, including a 4.6 out of 5 rating from members who saw a Counsel physician, and no clinical outcome data; Oura says it has more than 6 million members.
  • Google Cloud released Gemini for Healthcare in preview Nov. 10, with HCA Healthcare, Highmark Health and Northwell Health among launch partners; Fortune also listed Optum, Blue Cross Blue Shield of Massachusetts, Hartford HealthCare and Stanford School of Medicine. The tool summarizes records, flags conflicts, prepares and reviews prior authorizations and checks coverage, citing a source for each finding; for now it can read Epic records but not change them, Fortune reported. Northwell chief executive John D'Angelo told Fortune he has about 400 employees whose sole job is fighting insurance denials and that Northwell overturns more than 90% of them.
    Sources: Google, Fortune
  • HCA Healthcare expects about 10,000 physicians to be using its Commure ambient documentation tool by the end of 2026, chief clinical officer Dr. Michael Schlosser told Becker's, and the tool saves about five minutes per note, or one to two hours per shift. Becker's reported that outpatient clinics have seen increased throughput as physicians chose to add patients to their schedules. HCA plans a companywide rollout by the end of 2027.
  • Across 2,080,765 adult encounters at 15 Danish hospitals from 2018 to 2023, a gradient-boosting model using vital signs, demographics, laboratory values and medical-history text gained at most 1.9 correct 24-hour mortality identifications per 10,000 patients over the National Early Warning Score, according to a retrospective study in The Lancet Digital Health. In patients whose first score was 7 or higher, the model gained up to 78.1 per 10,000; for scores of 0 to 4 the differences were under 1 per 10,000.
  • Inference-time activation steering, which alters a language model's internal activations without changing its weights or system prompt, shifted an open-weights model's depression advice between antidepressants and self-care across 372 responses to 12 synthetic scenarios, Dr. Roy Perlis of Massachusetts General Hospital reported in JAMA Network Open. The shift was largest when the simulated patient stated no treatment preference, and 87% of responses still advised seeing a clinician. Perlis wrote that the change would be invisible to a patient or clinician and that the results suggest a need for independent auditing.

Comments on the proposals by two Medicare contractors, Palmetto GBA and Noridian, to stop covering AI quantification of brain MRI close Nov. 14. HLTH meets in Las Vegas Nov. 15 to 18. The FDA's draft guidance on robotically assisted surgical devices takes comments through Nov. 24, and RSNA convenes in Chicago Nov. 29 to Dec. 3.

Comments on Sen. Bill Cassidy's PATIENT AI Act discussion draft, which would create a Medicare payment pathway for AI tools, are due Dec. 1. The FDA holds a public workshop on autonomous and remotely operated robotic devices Dec. 2 and 3, and Oura expects its purchase of Counsel Health to close before the end of the year.

Latest news

  1. The U.S. no longer counts as measles-free after 26 years, a regional commission found, news outlets report
  2. Medicaid work rules still start Jan. 1, but states may hold off coverage losses until June 30, 2027
  3. Houston Methodist wants AI vendors to show staff reductions, not just hours saved, before it buys

See all the latest news